VivoSeq
Other

Opioid Misuse

0

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Opioid Misuse is an early-stage landscape with 0 programs across 1 company. The most active players are Tyra Boomer.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

T

Tyra Boomer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed3 · 60%
Recruiting1 · 20%
Active, not recruiting1 · 20%

Clinical Trials

Trial Activity

Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms
Recruiting·VVanderbilt University Medical Center·N/A·NCT05142267·120 enrolled
A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse
Completed·—·Phase 4·NCT03033732·272 enrolled
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention (STOMP-AI)
Active, not recruiting·UUniversity of Wisconsin, Madison·Preclinical·NCT06527599·118 enrolled
A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-based Health Centers (Randomized Controlled Trial)
Completed·—·Preclinical·NCT04941950·533 enrolled
Consensus-based Algorithms to Address Opioid Misuse Behaviors Among Individuals Prescribed Long-term Opioid Therapy: Developing Implementation Strategies and Pilot Testing
Completed·UUniversity of Pittsburgh·Preclinical·NCT05182606·49 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)